Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA

Author(s)

• 

  Brittany L. Siontis, MD

  Assistant Professor
  Mayo Clinic
  Rochester, Minnesota, United States

  Slides PDF

Co-Author(s)

• LZ

  Lili Zhao, PhD

  University of Michigan
  Ann Arbor, Michigan, United States
• 

  Scott M. Schuetze, MD, PhD (he/him/his)

  Professor of Internal Medicine
  University of Michigan
  Ann Arbor, Michigan, United States
• AF

  Amanda Fox, PA-C

  University of Michigan
  Ann Arbor, Michigan, United States
• LZ

  Laurie Zyczynski, PA-C (she/her/hers)

  Physician Assistant
  University of Michigan
  Ann Arbor, Michigan, United States
• SR

  Steven I. Robinson, MBBS

  Associate Professor of Oncology
  Mayo Clinic
  Rochester, Minnesota, United States
• SO

  Scott Okuno, MD

  Professor of Oncology
  Mayo Clinic
  Rochester, Minnesota, United States
• 

  Thanh P. Ho, MD

  Assistant Professor
  Mayo Clinic
  Rochester, Minnesota, United States
• 

  Rashmi Chugh, MD

  Professor of Internal Medicine
  University of Michigan
  Ann Arbor, Michigan, United States